New innovations in the era of glycobiology research

International Conference on Glycobiology

International Conference on Glycobiology (Glycobiology Conference 2017) will be held in Houston, USA in September 21-22, 2017. The conference will bring together biochemists, scientists, molecular biologists, industry experts, delegates, sponsors and exhibitors from all around the world to the splendid city of Houston, USA. The conference focuses on the theme "New innovations in the era of glycobiology research".

Glycobiology is a vast subject that includes the structure, biosynthesis, and biology of saccharides. It is the booming field in the area of research related to biomolecules which includes the study of metabolism and pathways, the prediction of the structure of biomolecules and many others etc.

Why to attend???

With members from all around the world have focused on learning more about biomolecules and Glycobiology, this is your best chance to meet the participants in the arena of Glycobiology, share information, meet current and potential scientists and receive name recognition in this 2-day premier event. 

Target Audience:



Scientists and Researchers

Biochemistry Experts

Medical Colleges

Biochemistry Associations and Societies

Business Entrepreneurs

Training Institutes

Pharma Companies

Pulsus Group Inc. is an internationally renowned peer-review publisher in scientific, technical, and medical journals established in the year 1984 with offices in Ontario, Canada and Hyderabad, India. Pulsus acquired Andrew John Publishing and open to expand its Open Access Publishing through its 50+ journals in association with 20+ International medical and scientific societies.

Pulsus through its is been very instrumental to provide an invaluable channel for scientists and researchers to exchange ideas and research by creating a forum for discussing the possibilities of future collaborations between universities, institutions, research bodies and organizations from different countries through international CME/CPD accredited conferences and meetings.

Houston, USA

September 21-22, 2017

Register for the Conference

Conference News

Scientific Sessions


Glycobiology is the study of the structure, biosynthesis and biology of saccharides that are widely distributed in nature. Sugars or saccharides are essential components of all living things and aspects of the various roles they play in biology and are researched in various medical, biochemical and biotechnological fields. The study of glycan structures is also complicated by the lack of a direct template for their biosynthesis, contrary to the case with proteins where their amino acid sequence is determined by their corresponding gene.

Glycobiology and Medicine

Drugs already on the market such as heparin, erythropoietin and a few anti-flu drugs have proven effective and highlight the importance of glycans as a new class of drug. Additionally, the search for new anti-cancer drugs is opening up new possibilities in glycobiology. Anti-cancer drugs with new and varied action mechanisms together with anti-inflammatory and anti-infection drugs are today undergoing clinical trials. They may alleviate or complete current therapies. Although these glycans are molecules that are difficult to synthesize in a reproducible way owing to their complex structure and this new field of research is highly encouraging for the future.

Glycobiology and Proteomics

Glycans are secondary gene products and therefore are generated by the coordinated action of many enzymes in the subcellular compartments of a cell. Multiple Reaction Monitoring (MRM) is a mass spectrometry-based technique that has recently been used for site-specific glycosylation profiling. Although MRM has been used extensively in metabolomics and proteomics, its high sensitivity and linear response over a wide dynamic range make it especially suited for glycan biomarker research and discovery.

Glycoconjugates and Glycomics

Glycomics analogous to genomics and proteomics is the systematic study of all the glycan structures of a given cell type or organism and is a subset of glycobiology. Sugars may be linked to other types of biological molecule to form glycoconjugates. The enzymatic process of glycosylation creates sugars or saccharides linked to themselves and to other molecules by the glycosidic bond, thereby producing glycans. Glycoproteins, proteoglycans and glycolipids are the most abundant glycoconjugates found in mammalian cells. Glycoconjugates have been shown to be important in cell-cell interactions due to the presence on the cell surface of various glycan binding receptors in addition to the glycoconjugates themselves.

Glycobiology and Glycochemistry

Glycans can be found attached to the proteins as in glycoproteins and proteoglycans. Carbohydrates have long been underappreciated by the scientific community and many scientists approach the complex structures and elaborate nomenclature of carbohydrates with trepidation. Like amino acids and nucleic acids, sugars are abundant in nature many natural products contain oligosaccharides that are vital for their biological activity and carbohydrates have key roles in a broad range of biological processes including signal transduction and immune responses.

Glycosciences and Monosaccharides

Glycoscience has become a vibrant, expanding and important extension of modern molecular biology and medicine. The wide complexity of glycosylated structures is only paralleled to their utility. Discovering carbohydrate antigens as tumour markers or even abnormal glycation pathways in metabolic diseases such as diabetes precluded the importance of the expansion of Glycoscience in a near future, as a way of disclosing new biomarkers and therapeutic targets in disease. The ultimate goal is to build research capacity on Glycosciences and seed ground to translate emerging discoveries in Glycosciences into new diagnostics and clinical applications.

Glycobiology and Protein Biochemistry

Proteins are a primary constituent of living things and one of the chief classes of molecules studied in biochemistry. Proteins provide most of the molecular machinery of cells. Many are enzymes or subunits of enzymes. Other proteins play structural or mechanical roles, such as those that form the struts and joints of the cytoskeleton. The study of proteins through protein biochemistry and enzymology encompasses many fields of biology, including molecular biology, cell biology, pharmaceutical research and development, food science, plant biology and more.

Recent Advances in Glycobiology

Glycobiology is one of the vast expanding fields. In the course of time many advances have taken place and huge number of solved structures has amplified rapidly. The field of drug design and molecular modelling has been advanced. Functional annotations are another field where progressions are being seen. Alterations in order to improve the effectiveness of prevailing tools can also be noted. Many remarkable advances can be seen in the areas of imaging technologies and advancement of hybrid methods to understand the structure and function of proteins.

Market Research

Glycobiology Market Global Forecast to 2019: The Glycobiology market will reach $928.11 million by 2019, growing at a CAGR of 12.62% during the forecast period (2014–2019). This report segment the global Glycobiology market by application, end users, products, and geographies. According to the World Bank, funding for research and development activities in Asia was about $158.94 billion in 2001 and increased to $329.31 billion in 2010. Similarly, in the U.S., overall funding for research and development was about $291.77 billion in 2001, which increased to $428.94 billion in 2010. Increased funding activities are expected to positively impact the growth of the Glycobiology enzymes, instruments, kits, and reagents market. A combination of bottom-up and top-down approaches were used to calculate market sizes and growth rates of the global Glycobiology enzymes.

Media Partners

Media Partners & Collaborators

Join us